Global EditionPremium world briefings with timeline, impact, and future-watch analysis.
New Zealand drugs regulator approves use of MDMA to treat severe PTSD
HealthThe Guardian04 Sept, 10:31 amAtlasHour
Health

New Zealand drugs regulator approves use of MDMA to treat severe PTSD

New Zealand decision follows Australian approval in 2023 of psychedelics to treat PTSD and treatment-resistant depression Two psychiatrists in New Zealand won approval on Friday to prescribe pharmaceutical-grade MDMA to people with severe post-traumatic stress disorder (PTSD). The move by New Zealand’s pharmaceutical regulatory body Medsafe makes the country only the second worldwide to approve the party drug for use in treating PTSD, following Australia in 2023...

Source-linkedAtlasHour DeskThe Guardian04 Sept, 10:31 am

What happened

New Zealand decision follows Australian approval in 2023 of psychedelics to treat PTSD and treatment-resistant depression Two psychiatrists in New Zealand won approval on Friday to prescribe pharmaceutical-grade MDMA to people with severe post-traumatic stress disorder (PTSD).

Why it matters

AtlasHour context: this story may affect public policy, global affairs, business confidence, technology direction, energy security, or civic life.

Global context

The story is being tracked through Global Markets.

Who is affected

Global Markets

What to watch next

Readers should watch official responses, local reaction, source updates, and whether the story changes the next decision cycle.

Read the original source
Why It Matters

The consequence layer

AtlasHour context: this story may affect public policy, global affairs, business confidence, technology direction, energy security, or civic life.

Watch Next

What To Watch Next

Key Facts

Three facts to keep in view

1Source

The Guardian

1 min readRead time

Designed for a concise world-news brief.

1Context tags

Used for editorial story mapping and source context.

Read Next

Related Stories

AtlasHour updates articles as new verified information becomes available. Corrections and source context can be sent to the newsroom.